Science Corporation’s brain tech is worth $3.5 billion after new funding

Science Corp has raised $400 million in Series D funding to scale its anti-blindness technology business. The round values the company at $3.5 billion, reflecting confidence in its AI-driven approach to treating vision loss.
Why it matters
The investment signals that AI-driven medical devices for treating blindness are reaching commercialization scale and attracting substantial capital for clinical deployment.


